Search - tctmd.com

Displaying 21 - 39 of 39

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cedars-Sinai Medical Center (USA)

Presenter: Tarun Chakravarty

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Erasmus University (The Netherlands)

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ulm University (Germany)

Presenter: Julia Seeger

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Presenter: Eberhard Grube, Tamim Nazif, Hemal Gada

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Presenter: Eberhard Grube, Tamim Nazif, Chetan P. Huded

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Presenter: Eberhard Grube, Tamim Nazif, Alexandra J. Lansky

June 21, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

News Industry News

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

May 02, 2018

Presentation SCAI 2018

Cerebral Embolic Protection: Protect Everyone

Presenter: Samir Kapadia

April 28, 2018

Presentation SCAI 2018

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Presenter: Steven J Yakubov

April 28, 2018

News Conference News SCAI 2018

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Shelley Wood

April 28, 2018

Update on Mitral Valve Disease and Transcatheter Therapies for Non-Aortic Valves

Presentation Fellows 2018

Cerebral Embolic Protection: A New Standard of Care?

Presenter: Susheel K. Kodali

April 15, 2018

News Conference News ISET 2018

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

Caitlin E. Cox

February 07, 2018

News Daily News

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Caitlin E. Cox

February 05, 2018

Partner Content

Boston Scientific - Cerebral Embolic Protection with Sentinel in TAVR: Shifting the Paradigm Toward Standard of Care

October 15, 2018

Partner Content

Keystone Heart - The Case for Complete Cerebral Embolic Protection - REFLECT

October 15, 2018

Partner Content

Cerebral Embolic Protection: From Emerging Technology to Standard of Care

June 27, 2018

Video

» Topical Discussion

TAVR: Future of Cerebral Embolic Protection

May 11, 2018

Advertisement

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Cedars-Sinai Medical Center (USA)

Erasmus University (The Netherlands)

Ulm University (Germany)

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

Cerebral Embolic Protection: Protect Everyone

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Cerebral Embolic Protection: A New Standard of Care?

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Boston Scientific - Cerebral Embolic Protection with Sentinel in TAVR: Shifting the Paradigm Toward Standard of Care

Keystone Heart - The Case for Complete Cerebral Embolic Protection - REFLECT

Cerebral Embolic Protection: From Emerging Technology to Standard of Care

TAVR: Future of Cerebral Embolic Protection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content